Pharmacologic Prevention of Noise and Drug-induced Hearing Loss: Current State of Development of Antioxidant Otoprotection

Abstract

Abstract Within the next decade audiologists will be working with patients and physicians in selecting and monitoring pharmacologic otoprotective agents against drug and noise induced hearing loss either for research or clinic applications or both. Currently, several of these agents are in clinical trials, although none yet have Food and Drug Administration approval for clinical use.